A Call for ‘Smarter’ Immunotherapy Clinical Trials – Cancer Network
|
A Call for 'Smarter' Immunotherapy Clinical Trials
Cancer Network Immunotherapy has ushered in a new golden age of cancer treatment. Checkpoint inhibitors have offered new hope in the battling a variety of cancers. However, only about 20% of patients who receive these agents are benefitting. It is believed combining … |
